ALTIMMUNE INC (ALT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ALT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALT | Director | 74 | ["Served as President and Chief Executive Officer of PharmAthene from March 2015 until May 2017","Co-founder and Director of TetraLogic Pharmaceuticals Corporation from 2003 to 2013","Experience at 3 Dimensional Pharmaceuticals and SmithKline Beecham","Served in the United States Marine Corps","B.A. in Accounting and Economics from Rutgers University"] | [] | 2026 |
Biography sourced from the proxy statement filing.
John M. Gill ( 74 ) has served as a member of our Board of Directors since August 2004. Mr. Gill served as PharmAthene s President and Chief Executive Officer from March 2015 until the completion of the Merger in May 2017. From 2003 to 2013, Mr. Gill served as the President, Chief Executive Officer, co-founder and a Director of TetraLogic Pharmaceuticals Corporation, a biopharmaceutical company. Mr. Gill has previously held positions at 3 Dimensional Pharmaceuticals and SmithKline Beecham. After serving in the United States Marine Corps, Mr. Gill earned a B.A. in Accounting and Economics from Rutgers University. We believe Mr. Gill s executive leadership, including his experience founding and leading publicly traded biopharmaceutical companies, combined with his financial acumen, operational oversight and board experience makes him well qualified to serve as a member of our Board of Directors to help guide our strategic-decision-making, corporate governance and long-term value creation.